Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Stangier, 2005, Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement, J Clin Pharmacol, 45, 555, 10.1177/0091270005274550

Eriksson, 2005, A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial, J Thromb Haemost, 3, 103, 10.1111/j.1538-7836.2004.01100.x

Eriksson, 2004, Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I, J Thromb Haemost, 2, 1573, 10.1111/j.1538-7836.2004.00890.x

Colwell, 1995, Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty, Clin Orthop Relat Res, 319, 215

Fitzgerald, 2001, Prevention of venous thromboembolic disease following primary total knee arthroplasty, J Bone Joint Surg Am, 83, 900, 10.2106/00004623-200106000-00012

Comp, 2001, Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement, J Bone Joint Surg Am, 83, 336, 10.2106/00004623-200103000-00004

Kalebo, 1996, Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment, Thromb Haemost, 76, 893, 10.1055/s-0038-1650682

Rabinov, 1972, Roentgen diagnosis of venous thrombosis in the leg, Arch Surg, 104, 134, 10.1001/archsurg.1972.04180020014004

Kalebo, 1997, Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trials, Acta Radiol, 38, 320, 10.1080/02841859709172072

Committee for Proprietary Medicinal Products. Points to consider on clinical investigation of medicinal products for prophylaxis of intra- and post-operative venous thromboembolic risk. London: The European Agency for the Evaluation of Medicinal Products, 2000 Jun 29. Guideline no. CPMP/EWP/707/98.

Leclerc, 1992, Prevention of deep vein thrombosis after major knee surgery—a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo, Thromb Haemost, 67, 417, 10.1055/s-0038-1648463

Kearon, 2003, Duration of venous thromboembolism prophylaxis after surgery, Chest, 124, 386, 10.1378/chest.124.6_suppl.386S

Eriksson, 2007, Dabigatran etexilate vs enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL Randomized Trial, J Thromb Haemost, 5, 2178, 10.1111/j.1538-7836.2007.02748.x